Correlation Between Gilead Sciences and Regulus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Regulus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Regulus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Regulus Therapeutics, you can compare the effects of market volatilities on Gilead Sciences and Regulus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Regulus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Regulus Therapeutics.
Diversification Opportunities for Gilead Sciences and Regulus Therapeutics
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Gilead and Regulus is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Regulus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regulus Therapeutics and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Regulus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regulus Therapeutics has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Regulus Therapeutics go up and down completely randomly.
Pair Corralation between Gilead Sciences and Regulus Therapeutics
Given the investment horizon of 90 days Gilead Sciences is expected to generate 2.39 times less return on investment than Regulus Therapeutics. But when comparing it to its historical volatility, Gilead Sciences is 1.77 times less risky than Regulus Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Regulus Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 149.00 in Regulus Therapeutics on September 2, 2024 and sell it today you would earn a total of 12.00 from holding Regulus Therapeutics or generate 8.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gilead Sciences vs. Regulus Therapeutics
Performance |
| Timeline |
| Gilead Sciences |
| Regulus Therapeutics |
Gilead Sciences and Regulus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gilead Sciences and Regulus Therapeutics
The main advantage of trading using opposite Gilead Sciences and Regulus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Regulus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regulus Therapeutics will offset losses from the drop in Regulus Therapeutics' long position.| Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
| Regulus Therapeutics vs. Tenax Therapeutics | Regulus Therapeutics vs. Verastem | Regulus Therapeutics vs. Pulmatrix | Regulus Therapeutics vs. Cellectar Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |